目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global orphan drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global orphan drugs market 2017 - 2021 ($ billion)
4.2 Distributed Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distributed Channel Segment 2017 - 2021 ($ billion)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
6.4 Specialty pharmacy - Market size and forecast 2022-2027
Exhibit 38: Chart on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
6.5 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 42: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Distribution Channel
Exhibit 50: Market opportunity by Distribution Channel ($ billion)
Exhibit 51: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 52: Chart on Product - Market share 2022-2027 (%)
Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 54: Chart on Comparison by Product
Exhibit 55: Data Table on Comparison by Product
7.3 Biologics - Market size and forecast 2022-2027
Exhibit 56: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
7.4 Non-biologics - Market size and forecast 2022-2027
Exhibit 60: Chart on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Non-biologics - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Non-biologics - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 64: Market opportunity by Product ($ billion)
Exhibit 65: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Alnylam Pharmaceuticals Inc.
Exhibit 119: Alnylam Pharmaceuticals Inc. - Overview
Exhibit 120: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibit 121: Alnylam Pharmaceuticals Inc. - Key news
Exhibit 122: Alnylam Pharmaceuticals Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 123: Astellas Pharma Inc. - Overview
Exhibit 124: Astellas Pharma Inc. - Product / Service
Exhibit 125: Astellas Pharma Inc. - Key news
Exhibit 126: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 127: AstraZeneca Plc - Overview
Exhibit 128: AstraZeneca Plc - Product / Service
Exhibit 129: AstraZeneca Plc - Key news
Exhibit 130: AstraZeneca Plc - Key offerings
12.7 bluebird bio Inc.
Exhibit 131: bluebird bio Inc. - Overview
Exhibit 132: bluebird bio Inc. - Product / Service
Exhibit 133: bluebird bio Inc. - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 134: Bristol Myers Squibb Co. - Overview
Exhibit 135: Bristol Myers Squibb Co. - Product / Service
Exhibit 136: Bristol Myers Squibb Co. - Key news
Exhibit 137: Bristol Myers Squibb Co. - Key offerings
12.9 CSL Ltd.
Exhibit 138: CSL Ltd. - Overview
Exhibit 139: CSL Ltd. - Business segments
Exhibit 140: CSL Ltd. - Key news
Exhibit 141: CSL Ltd. - Key offerings
Exhibit 142: CSL Ltd. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Gilead Sciences Inc.
Exhibit 148: Gilead Sciences Inc. - Overview
Exhibit 149: Gilead Sciences Inc. - Product / Service
Exhibit 150: Gilead Sciences Inc. - Key news
Exhibit 151: Gilead Sciences Inc. - Key offerings
12.12 GlaxoSmithKline Plc
Exhibit 152: GlaxoSmithKline Plc - Overview
Exhibit 153: GlaxoSmithKline Plc - Business segments
Exhibit 154: GlaxoSmithKline Plc - Key news
Exhibit 155: GlaxoSmithKline Plc - Key offerings
Exhibit 156: GlaxoSmithKline Plc - Segment focus
12.13 Ipsen Pharma
Exhibit 157: Ipsen Pharma - Overview
Exhibit 158: Ipsen Pharma - Business segments
Exhibit 159: Ipsen Pharma - Key offerings
Exhibit 160: Ipsen Pharma - Segment focus
12.14 Johnson and Johnson Services Inc.
Exhibit 161: Johnson and Johnson Services Inc. - Overview
Exhibit 162: Johnson and Johnson Services Inc. - Business segments
Exhibit 163: Johnson and Johnson Services Inc. - Key news
Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
12.15 Merck and Co. Inc.
Exhibit 166: Merck and Co. Inc. - Overview
Exhibit 167: Merck and Co. Inc. - Business segments
Exhibit 168: Merck and Co. Inc. - Key news
Exhibit 169: Merck and Co. Inc. - Key offerings
Exhibit 170: Merck and Co. Inc. - Segment focus
12.16 Novartis AG
Exhibit 171: Novartis AG - Overview
Exhibit 172: Novartis AG - Business segments
Exhibit 173: Novartis AG - Key offerings
Exhibit 174: Novartis AG - Segment focus
12.17 Ractigen Therapeutics
Exhibit 175: Ractigen Therapeutics - Overview
Exhibit 176: Ractigen Therapeutics - Product / Service
Exhibit 177: Ractigen Therapeutics - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global orphan drugs market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Distributed Channel Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Specialty pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Specialty pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Distribution Channel ($ billion)
Exhibits51: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits52: Chart on Product - Market share 2022-2027 (%)
Exhibits53: Data Table on Product - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Non-biologics - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Non-biologics - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Non-biologics - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Product ($ billion)
Exhibits65: Data Table on Market opportunity by Product ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Alnylam Pharmaceuticals Inc. - Overview
Exhibits120: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits121: Alnylam Pharmaceuticals Inc. - Key news
Exhibits122: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits123: Astellas Pharma Inc. - Overview
Exhibits124: Astellas Pharma Inc. - Product / Service
Exhibits125: Astellas Pharma Inc. - Key news
Exhibits126: Astellas Pharma Inc. - Key offerings
Exhibits127: AstraZeneca Plc - Overview
Exhibits128: AstraZeneca Plc - Product / Service
Exhibits129: AstraZeneca Plc - Key news
Exhibits130: AstraZeneca Plc - Key offerings
Exhibits131: bluebird bio Inc. - Overview
Exhibits132: bluebird bio Inc. - Product / Service
Exhibits133: bluebird bio Inc. - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: CSL Ltd. - Overview
Exhibits139: CSL Ltd. - Business segments
Exhibits140: CSL Ltd. - Key news
Exhibits141: CSL Ltd. - Key offerings
Exhibits142: CSL Ltd. - Segment focus
Exhibits143: F. Hoffmann La Roche Ltd. - Overview
Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits145: F. Hoffmann La Roche Ltd. - Key news
Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits148: Gilead Sciences Inc. - Overview
Exhibits149: Gilead Sciences Inc. - Product / Service
Exhibits150: Gilead Sciences Inc. - Key news
Exhibits151: Gilead Sciences Inc. - Key offerings
Exhibits152: GlaxoSmithKline Plc - Overview
Exhibits153: GlaxoSmithKline Plc - Business segments
Exhibits154: GlaxoSmithKline Plc - Key news
Exhibits155: GlaxoSmithKline Plc - Key offerings
Exhibits156: GlaxoSmithKline Plc - Segment focus
Exhibits157: Ipsen Pharma - Overview
Exhibits158: Ipsen Pharma - Business segments
Exhibits159: Ipsen Pharma - Key offerings
Exhibits160: Ipsen Pharma - Segment focus
Exhibits161: Johnson and Johnson Services Inc. - Overview
Exhibits162: Johnson and Johnson Services Inc. - Business segments
Exhibits163: Johnson and Johnson Services Inc. - Key news
Exhibits164: Johnson and Johnson Services Inc. - Key offerings
Exhibits165: Johnson and Johnson Services Inc. - Segment focus
Exhibits166: Merck and Co. Inc. - Overview
Exhibits167: Merck and Co. Inc. - Business segments
Exhibits168: Merck and Co. Inc. - Key news
Exhibits169: Merck and Co. Inc. - Key offerings
Exhibits170: Merck and Co. Inc. - Segment focus
Exhibits171: Novartis AG - Overview
Exhibits172: Novartis AG - Business segments
Exhibits173: Novartis AG - Key offerings
Exhibits174: Novartis AG - Segment focus
Exhibits175: Ractigen Therapeutics - Overview
Exhibits176: Ractigen Therapeutics - Product / Service
Exhibits177: Ractigen Therapeutics - Key offerings
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations